Regional News
20 more colleges and universities select Boldyn Networks to advance campus connectivity and IT operations
New and expanded partnerships help institutions strengthen the student
residential experience, increase IT capacity and modernize campus connectivity
NEW YORK, Sept. 28, 2026 /PRNewswire/ -- Driven by growing demand from higher
education institutions, Boldyn Networks
2026-09-28 22:00
3157
Open-Source Model Accelerates Global Progress in Medical Video AI
SHANGHAI, Sept. 28, 2026 /PRNewswire/ -- Through an open-source model, a public dataset and benchmark, and the MedVidU Challenge, a global research competition, researchers worldwide now share a common foundation for advancing medical video AI. The Challenge drew 75 teams from 18 countries and re...
2026-09-28 21:19
3769
Unlock Restorative Sleep This Prime Day: Save Up to 55% on Breescape Cooling Bedding
Prime members can save on award-winning cooling sheets, comforters, mattress
toppers, and pillows during Amazon's October Prime Day event on Oct. 6 and 7
NEW YORK, Sept. 28, 2026 /PRNewswire/ -- As temperatures drop and shoppers
get ready for Amazon's biggest fall sale,Breescape
2026-09-28 21:00
2320
Lunit Expands AI-Powered Breast Cancer Screening Across the Stockholm Region
Following years of clinical validation and proven real-world performance at Saint Göran, Stockholm Region adopts Lunit INSIGHT MMG as an independent second reader at regional scale SEOUL, South Korea, Sept. 28, 2026 /PRNewswire/ -- Lunit (KRX:328130), a leading provider of AI for cancer diagnost...
2026-09-28 21:00
2770
Pearson and Namibox Sign Strategic Cooperation Memorandum, Join Forces to Shape a New Global Learning and Education Landscape in the AI Era
SHANGHAI, Sept. 28, 2026 /PRNewswire/ -- During the 48th WorldSkills Competition, Pearson (NYSE: PSO), a global lifelong learning company, and Namibox (Nasdaq: NAMI), a China-based K-12 digital education platform, formally signed a strategic cooperation memorandum. The two parties will leverage ...
2026-09-28 21:00
3664
Why has Chinese civilization endured?
BEIJING, Sept. 28, 2026 /PRNewswire/ -- A news report from China.org.cn on China National Archives of Publications and Culture: Why has Chinese civilization endured? Chinese civilization has endured for 5,000 years, making it the world's only continuous civilization with indigenous origins. Why...
2026-09-28 21:00
3143
TOYO Announces Approximately $240 Million in Binding U.S. Solar Module Supply Agreements Through First Half of 2027
TOKYO, Sept. 28, 2026 /PRNewswire/ -- TOYO Co., Ltd. (Nasdaq: TOYO) (OTC: TOYWF) ("TOYO" or the "Company"), a solar manufacturing company, today announced that, since mid-June 2026, it has entered into multiple binding solar photovoltaic module supply agreements with an aggregate contract value o...
2026-09-28 20:15
6305
Amber International Holding Limited Schedules 2026 Annual General Meeting for October 23, 2026
SINGAPORE, Sept. 28, 2026 /PRNewswire/ -- Amber International Holding Limited ("Amber International" or the "Company") (NASDAQ: AMBR), today announced that it will hold its 2026 annual general meeting on October 23, 2026 at 9:00 a.m. (Singapore time) or on October 22, 2026 at 9:00 p.m. (New York ...
2026-09-28 19:31
4531
Bridging Vocational Education and Writing a New Chapter of Youthful Excellence in the SCO
Luban Workshop Innovation and Development Conference and "Gen Z" Youth Summer Camp Held in Tianjin BEIJING, Sept. 28, 2026 /PRNewswire/ -- This is a report from China Daily: Luban Workshop Innovation and Development Conference and “Gen Z" Youth Summer Camp Held in Tianjin The Luban Workshop I...
2026-09-28 18:42
1814
Jaypirca® (pirtobrutinib) Approved in China for a New Indication in Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) Across All Lines of Therapy
SAN FRANCISCO and SUZHOU, China, Sept. 28, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabol...
2026-09-28 18:30
2798
KIST Accelerates Global Expansion for Korean Quantum Deep-Tech Startups at Quantum World Congress 2026
Delegation secures strategic ties with D-Wave, Microsoft, and AIST while paving the way for U.S. market entry and regional operations. SEOUL, South Korea and COLLEGE PARK, Md., Sept. 28, 2026 /PRNewswire/ -- The Korea Institute of Science and Technology (KIST) has successfully led a delegation o...
2026-09-28 18:23
2415
111, Inc. Announces Establishment of the Special Committee
SHANGHAI, Sept. 28, 2026 /PRNewswire/ -- 111, Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, announced today that the special committee (the "Special Committee"), comprising of three independent directors, Mr. Jian Sun, who is the chairma...
2026-09-28 16:30
4126
Autumn in Shaanxi: Unlock "Shaanximaxxing"
XI'AN, China, Sept. 28, 2026 /PRNewswire/ -- As "Chinamaxxing" continues to capture travelers' interest in Chinese culture and everyday life, Shaanxi offers its own take on the trend this autumn — Shaanximaxxing. Ancient ginkgo trees are turning gold, forests across the Qinling Mountains are chan...
2026-09-28 15:19
1719
SOLA Biosciences Japan Receives AMED Grant to Advance SOL-257, Innovative Gene Therapy Aiming to Restore TDP-43 Function for ALS Patients
TOKYO and BOSTON, Sept. 28, 2026 /PRNewswire/ -- SOLA Biosciences Japan GK ("SOLA Japan"), the wholly owned Japanese subsidiary of Boston-based SOLA Biosciences Inc. (together, "SOLA"), announced that it has been awarded a grant of approximately 6 billion yen over five years by the Japan Agency f...
2026-09-28 14:00
2798
59th CIFF Guangzhou: Power the Next. Celebrating 30 years, CIFF Guangzhou looks ahead to a new era of design, innovation and global business
GUANGZHOU, China, Sept. 28, 2026 /PRNewswire/ -- The 59th China International Furniture Fair (CIFF Guangzhou) will be held in Guangzhou Pazhou in two phases, onMarch 18–21 and March 28–31, 2027, marking an important milestone: 30 years since the foundation of CIFF. Under the theme "Power the Nex...
2026-09-28 13:20
2538
Akeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer
HONG KONG, Sep. 27, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that the first patient has been enrolled in COMPASSION-37 (AK104-311), a global, multicenter Phase III head-to-head trial evaluating cadonilimab, Akeso's first-in-class PD-1/CTLA-4 bispecific...
2026-09-28 10:05
4264
Innovent Announces Expansion of Global Phase 3 MarsLight-11 Study of IBI363/TAK-928 (Alpha-biased IL-2/PD-1 Bispecific Fusion Protein) in Immunotherapy-Resistant NSCLC to Include Patients with Non-Squamous NSCLC
SAN FRANCISCO and SUZHOU, China, Sept. 27, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (HKEX Stock Code: 01801), a biopharmaceutical company dedicated to the research, development, manufacturing, and commercialization of innovative drugs for major diseases including oncology, autoimmune, metabo...
2026-09-28 08:00
2975
AI Memory & Storage: The 5th GMIF2026 Innovation Summit Successfully Concludes in Shenzhen
SHENZHEN, China, Sept. 26, 2026 /PRNewswire/ -- On September 23, the 5th GMIF2026 Innovation Summit successfully concluded at the Renaissance Shenzhen Bay Hotel. Co-hosted by the Shenzhen Memory Industry Association (SMIA) and School of Integrated Circuits at Peking University, the summit, themed...
2026-09-27 23:59
3033
2026 IMS | IASO Bio Presented FUCASO China Real-World Data
--- In a large China real-world study of 281 heavily pretreated, predominantly high-risk patients with relapsed/refractory plasma cell neoplasms,FUCASO achieved a 95.9% objective response rate, a 77.2% CR/sCR rate, and a 94.1% MRD negativity rate --- with median PFS and OS not yet reached (12-mo...
2026-09-27 11:16
3150
2026 IMS | IASO Bio Presented First-in-Human Data of BCMA-Targeted In Vivo CAR-T Cell Therapy IASO206
— Late-breaking oral presentation of first-in-human data (LBA-11) showed that a single intravenous infusion of IASO206 generated functional BCMA CAR-T cells in vivo without lymphodepleting chemotherapy. The study demonstrated a 90% objective response rate and a 90% MRD negativity rate in a popula...
2026-09-27 11:03
8513
Week's Top Stories
Most Reposted
Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control
[Picked up by 1154 media titles]
2026-11-11 22:00Royal Bank of Canada announces agreement to acquire Yarra Capital Management
[Picked up by 1143 media titles]
2026-11-09 21:00Algolia Powers Orange with AI Agents for Billing Support: NYSE Content Update
[Picked up by 1121 media titles]
2026-11-06 22:06
Cision Report Reveals the Consumer Trends Hidden Between Search, Social, and AI
[Picked up by 1109 media titles]
2026-11-09 23:00
Poppi Founders Launch Hydration Brand jetty: NYSE Content Update
[Picked up by 1083 media titles]
2026-11-10 22:17
Most Read
Home Companion Robot Mobo to Debut Globally and Open Pre-orders as AiMOGA Showcases Its Robot Family at the 2026 OMODA & JAECOO International User Summit
2026-11-07 13:49
26968
ZD Energy Unveils Overseas Smart Energy Solutions in Thailand, Leveraging Local Manufacturing and Scenario-Based Capabilities to Support the Country's Energy Transition
2026-11-06 22:12
15893
SILVERSEA MARKS HISTORIC OPENING OF THE CORMORANT AT 55 SOUTH, THE SOUTHERNMOST HOTEL ON EARTH, OFFERING A NEW GATEWAY TO ANTARCTICA
2026-11-07 01:05
15334
Algolia Powers Orange with AI Agents for Billing Support: NYSE Content Update
2026-11-06 22:06
12475